Neonatal tetanus: An old enemy still lurking around in 2021
Article Sidebar
Main Article Content
Abstract
Neonatal tetanus (NT) is a severe but preventable disease for which South Africa achieved elimination status in 2000. It is under-reported, especially in poorly resourced areas where there is minimal surveillance and immunisation coverage is overestimated, and where traditional practices are employed. The case fatality rate is high and surviving infants often have significant morbidity. The aim of our case report is to alert clinicians to the presence of NT and its clinical presentation and to emphasise the value of notification and surveillance. Prevention of NT should be prioritised through: education around hygienic practices at delivery; ensuring adequate immunity against tetanus in all women through routine childhood immunisation; and administration of tetanus toxoid in each pregnancy. NT should be considered in any neonate who could suck and cry in the first 2 days of life and who, between 3 and 28 days of life, cannot suck normally and becomes stiff or has spasms.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
World Health Organization. Neonatal Tetanus. WHO Vaccine-Preventable Diseases Surveillance Standards. Geneva: WHO, 2018. https://www.who.int/ publications/m/item/vaccine-preventable-diseases-surveillance-standards- neonatal-tetanus (accessed 2 June 2021).
Burtis DB, Dobbs MR. Tetanus Toxin. In: Clinical Neurotoxicology. Amsterdam: Elsevier, 2009:427-435.
National Institute for Communicable Diseases. Annual Overview 2019/20. Johannesburg: NICD, 2020. https://www.nhls.ac.za/wp-content/ uploads/2021/07/NICD-Annual_Overview-2019_20.pdf (accessed 2 June 2021).
World Health Organization. Protecting all Against Tetanus. Geneva: WHO, 2019. https://www.who.int/immunization/documents/9789241515610/en/ (accessed 2 June 2021).
Idema CD, Harris BN, Ogunbanjo GA, Dürrheim DN. Neonatal tetanus elimination in Mpumalanga Province, South Africa. Trop Med Int Health 2002;7(7):622-624. https://doi.org/10.1046/j.1365-3156.2002.00903.x
Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Tetanus toxoid immunisation to reduce mortality from neonatal tetanus. Int J Epidemiol 2010;39(1):102-109. https://doi.org/10.1093/ije/dyq027